The number of children requiring pediatric intensive care unit (PICU) admission for severe acute asthma (SAA) around the world has increased.
Asthma is the most prevalent chronic disease of childhood, with a prevalence of 5-10% in children up to 12 years in the Netherlands. 1, 2 Acute asthma exacerbations are a significant burden to patients, their family and to public health worldwide.
Severe acute asthma (SAA) is defined as an acute asthma exacerbation that does not respond to conventional therapy with bronchodilators and systemic corticosteroids. SAA has the potential to progress to respiratory failure and can be fatal. 3 The 2006 national pediatric guideline for SAA in the Netherlands states that children whose asthma exacerbation does not respond in 30-60 min to conventional treatment should receive intravenous (IV) magnesium sulphate (40 mg/kg). The next step is continuous IV administration of salbutamol followed by immediate transfer to a pediatric intensive care (PICU), regardless of the dosage of salbutamol.
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A previous multicenter study on PICU admissions of children with SAA in the Netherlands showed the following risk factors that were significantly predictive for PICU admission: active or passive smoking, allergies, previous hospitalization for asthma, and non-sanitized homes. 5 These risk factors were congruent to studies in other countries and other populations. [6] [7] [8] In a recent study in the USA, treatment with inhaled corticosteroids (ICS) prior to the index hospitalization was a significant risk factor for ICU admission. 9 This might be due to the fact that children using ICS had more severe asthma and consequently a higher risk for SAA and PICU admission.
Other relevant risk factors for PICU admission are a shorter duration of illness before being admitted to the hospital, 6 time since asthma diagnosis 8 or viral infections. 10 SAA requiring PICU admission represents a major cost burden.
Additionally, PICU admission itself is associated with greater psychological morbidity in children and their parents, when compared with admissions in general pediatric wards. 11 Unexpected admission of a child to a PICU is a stressful event and is associated with posttraumatic stress disorder (PTSD) both in children and their parents. 12, 13 Numbers of asthma related PICU admissions have shown a substantial increase internationally. During a 15-year period in New Jersey (USA), fewer children with SAA were admitted to a hospital, but the proportion of patients managed in the PICU more than tripled. 14 A study in Saudi Arabia showed a fourfold increase of PICU admissions due to SAA in children in 2013 compared to a previous cohort in 2003. 15 In the last decade, a substantial increase in the number of children with SAA admitted to the PICU of the Erasmus MC-Sophia was observed. To see whether this was a local or national trend we embarked on a nationwide study.
The aim of the present study was to examine the trend in prevalence of PICU admissions of children with SAA in the Netherlands and to assess patient characteristics and asthma treatment in the last decade.
2 | METHODS
| Inclusion criteria
We conducted a retrospective cohort study of children with SAA, admitted to the eight PICUs in the Netherlands. These PICUs are part of university, tertiary hospitals. Children were identified through the Pediatric Intensive Care Evaluation (PICE) database, a national database containing all children admitted to Dutch PICUs.
All children aged 2-18 years admitted to one of the eight PICUs with SAA from January 2003 to December 2013 were eligible for this study. The SAA diagnosis had to be confirmed before PICU discharge.
Children <2 years of age, who are admitted at the PICU because of dyspnea generally have respiratory tract infections. In children below the age of 2 years no firm diagnosis of asthma could be made at the time of PICU discharge. 16, 17 All admissions and re-admissions were included in the study. Because of the retrospective design of the study, the Medical Ethics Committee waived the need for informed consent.
| Methods
We identified our patients from the PICE database. 18 The PICE registry was established in 2000 as an independent national nonprofit foundation to develop and maintain a continuous registration of data relating to all children admitted to all PICUs in the Netherlands.
The database contains anonymous information regarding characteristics of patients and admission, severity of illness and risk of mortality, treatment, and patient outcome.
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Two investigators retrieved all data from electronic patient records and paper chart review by using an electronic case report form created in Open Clinica. Data included demographic data, asthma diagnosis at time of admission, allergies, prescribed asthma treatment at home, SAA treatment at the referring hospital and PICU, and PICU mortality.
Inhaled or food allergies were defined as a positive radioallergosorbent test (RAST) or skin prick test, and/or reported by the treating physician or parents. Prescribed home asthma treatment was recorded if prescribed at least 7 days before the SAA and was categorized according to the global initiative for asthma (GINA). 17 We used the following parameters to assess SAA severity: first pH and PCO 2 obtained at PICU admission, length of stay (LOS) on a PICU, highest infusion rate of salbutamol IV, and PICU mortality. If missing data for describing SAA severity exceeded 20%, variables were excluded from the analyses. 
| Analyses

| RESULTS
We included 590 eligible children, with a total of 660 PICU admissions.
Baseline and PICU characteristics are described in Tables 1 and 2 . The median pH and PCO 2 at PICU admission showed an increase and decrease over time, respectively. There was no significant difference in LOS on the PICU (P = 0.637) or highest infusion rate of salbutamol (P = 0.712, Table 3 ). The number of patients treated with MgSO 4 and Medication step (GINA)
Step 1 169 (26) Step 2 196 (31)
Step 3 76 (12) Step 4 41 (6)
Step 5 IV salbutamol in the referring hospital increased significantly over time (Table 4) .
Over the years the proportion of steroid-naïve patients increased significantly (P = 0.004) ( Table 4) . The proportion of patients with a diagnosis of asthma prior to admission remained stable over the years (P = 0.086). In 118 admissions (19%) invasive mechanical ventilation was necessary due to cardiopulmonary resuscitation, secure airway and breathing for inter-hospital transport to the PICU and/or progressive respiratory failure (eg, hypoxemia, hypercapnia, apnea). The majority of the intubated patients received a dosage IV salbutamol of >1 mcg/kg/min and for >24 h during PICU admission. Intubated children had a significantly longer PICU LOS, lower pH and a higher PCO 2 at time of PICU admission than children not intubated. The proportion of steroidnaïve children was similar in the intubated and non-intubated group (Table 5 ). Over the years there was a statistically significant decreasing trend of percentage of mechanically ventilated children, from 24% in 2003
to 11% in 2013 (P < 0.001). High-flow nasal cannula was introduced in 2010, and showed an increase in the following years (Table 6 ).
During PICU admission 83% of the patients received IV salbutamol (Table 2) . Of these patients, 33% received a highest infusion rate of 0.5 mcg/kg/min and 58% a highest infusion rate of 1.0 mcg/kg/min (Table 7) . Seventeen percent (109 children) did not receive IV salbutamol during PICU admission. PICU LOS was significantly shorter in the group without IV salbutamol and more children were invasively mechanically ventilated. Other potential risk factors for IV salbutamol were not significant (Table 8 ).
Seven patients (1.1%) needed extracorporeal membrane oxygenation (ECMO). One patient was supported with venoarterial (VA)-
ECMO after extracorporeal cardiopulmonary resuscitation (eCPR).
This patient died during PICU admission (brain death). The others were supported with venovenous (VV)-ECMO, four due to refractory hypoxemia and two due to massive air leak syndrome.
Four patients died (0.6%) during the 11-year study period. Two of these patients were declared brain death following resuscitation. One patient died of respiratory failure and one of circulatory failure. All four experienced a cardiac arrest (n = 2 out-of-hospital, n = 1 in a general hospital, and n = 1 at the PICU). All fatalities were non-white males, had doctor-diagnosed asthma and were prescribed ICS. Three were known with allergies, of whom two also had a food allergy. 
FIGURE 2 Preschoolers versus school-aged children
in this North-American study, 20% of patients was younger than 2 years of age and comorbidities were not an exclusion criterium. The results of this heterogeneous study group cannot be compared to our study, given the difficulty in correctly diagnosing severe wheeze or asthma in that age group such as excluding bronchiolitis and viral lower airway infections. Of the patients admitted to a PICU in that study, 10% received mechanical ventilation, with no decrease over time compared to a decrease of 25-31 to 11% over time in our study. In that population, the length of stay at the PICU and the mortality rate also remained stable during this 15-year period. 14 What is the clinical relevance of the present findings? An increased frequency or severity of illness is not a likely cause of the threefold increase in PICU admissions, as the prevalence of asthma in children has remained stable in the Netherlands over these years, 27, 28 and the first blood gas pH and PCO 2 , duration of PICU admission and PICU mortality did not change over time. The number of PICU beds in the Netherlands increased by 1.9% and total PICU admissions increased with 38%, whereas the number of SAA PICU admissions increased disproportionately with a factor 3.
As we have no evidence to suggest that SAA severity increased, this may indicate a lower threshold for a PICU admission over time.
A possible explanation is that IV salbutamol has been administered sooner in the treatment work-up in the referring hospitals over the years. Our national SAA guideline automatically implies immediate referral to a PICU, regardless of IV salbutamol dosage. This recommendation should perhaps be reconsidered in the light of our findings.
A striking and unexpected observation was the marked increase in steroid-naïve children that were admitted with SAA over the years.
The interpretation of this finding may simply reflect a first asthmatic attack of a child not previously diagnosed having asthma. As the increase was in all age groups this might also indicate a significant increase of undertreatment of known asthma. Over the 11-year study period the proportion of children with no previous diagnosis of asthma remained the same. In a previous study, 5 we observed that about one third of children with SAA admitted to a PICU was not known with asthma prior to that admission. Studies in Taiwan and Saudi Arabia also showed a significant number of patients not using daily ICS prior to PICU admission, respectively, 20% and 46%, compared to 50% in our study. 21, 22 Non-invasive respiratory support with external positive endexpiratory pressure (PEEP) can relieve airway obstruction in children with asthma, 29 In our cohort, 10-20% of the patients did not receive any salbutamol infusion during PICU stay. Therefore, one could argue whether these children really met PICU admission criteria. It is likely that the referring clinician transferred these children to the PICU because of potential respiratory failure despite continuous nebulization and MgSO 4 IV, according to the Dutch guideline.
In our study PICU mortality was 0.6%. All fatalities experienced a cardiac arrest, three of them outside of a PICU. Hence, the prevention, recognition and management of SAA at home, by general practitioners and in a regional hospital is very important.
This also emphasizes the importance of proper maintenance treatment in children with asthma. Because of the already low mortality, it is not likely that more aggressive therapies will further reduce mortality.
Our national SAA guideline automatically implies immediate referral to a PICU, regardless of IV salbutamol dosage. This BOESCHOTEN ET AL.
| 863 recommendation should perhaps be reconsidered in the light of our findings. The high costs of PICU admission, bed availability but also risk of PTSD after PICU admission in children and their parents 12, 13 are drawbacks of the present development toward more frequent PICU admission. It is therefore important to reduce unnecessary PICU admissions. Priority should be given to adequate diagnosis and anti-inflammatory treatment (preventing undertreatment) of children with asthma to prevent PICU admissions, to perform prospective studies into the safety of low dosage IV salbutamol, and to increase alertness of risk factors for severe SAA.
| CONCLUSION
During the last decade we observed an important, threefold increase 
